Methyl 2-[(2-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-2-yl)formamido]-2-phenylacetate

Catalog No. :
ACKEXU780
CAS No. :
1008710-08-4
Molecular Formula :
C19H18N2O5
Molecular Weight :
354.36

IUPAC Name:methyl 2-(2-methyl-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazine-2-carboxamido)-2-phenylacetate

Methyl 2-[(2-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-2-yl)formamido]-2-phenylacetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$565.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 2-[(2-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-2-yl)formamido]-2-phenylacetate
IUPAC Namemethyl 2-(2-methyl-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazine-2-carboxamido)-2-phenylacetate
MDL No.MFCD04125004
Molecular FormulaC19H18N2O5
Molecular Weight354.36
SMILESO=C(OC)C(NC(C1(C)OC2=CC=CC=C2NC1=O)=O)C3=CC=CC=C3
InChI KeyXPFKNVVJNFVBFA-UHFFFAOYSA-N
SynonymMETHYL 2-([(2-METHYL-3-OXO-3,4-DIHYDRO-2H-1,4-BENZOXAZIN-2-YL)CARBONYL]AMINO)-2-PHENYLACETATE;methyl 2-[(2-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-2-yl)formamido]-2-phenylacetate;Benzeneacetic acid, α-[[(3,4-dihydro-2-methyl-3-oxo-2H-1,4-benzoxazin-2-yl)carbonyl]amino]-, methyl ester
CAS No.1008710-08-4

Synthetic Route by SureRoute

1. ACKEXU780 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJTOR350 route compound structure diagram
    ACJTOR35015028-40-7 In Stock
  4. Then
  5. ACKEXU780 route product structure diagram
    ACKEXU7801008710-08-4
Inquiry

2. ACKEXU780 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJTOR350 route compound structure diagram
    ACJTOR35015028-40-7 In Stock
  4. Then
  5. ACKEXU780 route product structure diagram
    ACKEXU7801008710-08-4
Inquiry

Comments (0)